Comparison of Application and Nursing between Continuous Hyperthermic Peritoneal Perfusion Chemotherapy and Intravenous Chemotherapy for Advanced Gastric Cancer Patients_West China Medical Journal

Authors：

 GaoHuijun ¹ ,  GanJianhui ²

1. Operation Room;Tangshan People's Hospital Affiliated to North China University of Science and Technology, Tangshan, Hebei 063000, P. R. China;
2. Department of Anesthesiology;Tangshan People's Hospital Affiliated to North China University of Science and Technology, Tangshan, Hebei 063000, P. R. China;

Corresponding?author：

GanJianhui, Email: gjh71@163.com

Keywords：

Nursing; Advanced gastric cancer; Continuous hyperthermic peritoneal perfusion; Chemotherapy

DOI：

10.7507/1002-0179.201600434

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To compare the clinical effects of continuous hyperthermic peritoneal perfusion chemotherapy (CHPPC) and intravenous chemotherapy for advanced gastric cancer patients, and find better nursing methods. Methods Sixty advanced gastric cancer patients who underwent chemotherapy between June 2013 and June 2014 were divided into CHPPC group (group C, n=30) and intravenous chemotherapy group (group V, n=30). We recorded the nursing methods for both the two groups, patients' satisfaction to the nursing and treatment, peritoneal metastasis rate and quality of life during the chemotherapy. Results The life quality in group V was lower than that in group C (P<0.05). The differences in patients' satisfaction rate, peritoneal metastasis rate, and one-year survival rate were not significantly different between the two groups (P>0.05). Conclusion For patients with advanced gastric cancer requiring chemotherapy, in spite of higher cost and more complicated operations, CHPPC is superior in lower adverse events rate, better quality of life during chemotherapy and doesn't decrease patients' satisfaction to the nursing and treatment.

Citation： GaoHuijun, GanJianhui. Comparison of Application and Nursing between Continuous Hyperthermic Peritoneal Perfusion Chemotherapy and Intravenous Chemotherapy for Advanced Gastric Cancer Patients. West China Medical Journal, 2016, 31(9): 1589-1591. doi: 10.7507/1002-0179.201600434 Copy

1.	龔海云. 70例中晚期惡性腫瘤患者全身熱療的觀察與護理[J]. 當代護士:學術版, 2008(3):49-51.
2.	馬蕊. 惡性腫瘤患者全身熱療護理體會[J]. 中國現代藥物應用, 2010, 4(11):180-181.
3.	趙改梅, 方慧. 惡性腫瘤患者全身熱療的護理體會[J]. 實用醫藥雜志, 2008, 25(8):962-963.
4.	黃麗君, 徐惠芳, 宋俊瑩, 等. 腹部中晚期惡性腫瘤熱療的護理探討[J]. 中國臨床保健雜志, 2015, 5(2):214-215.
5.	鄭劍菁. 晚期腫瘤患者深部熱療護理體會[J]. 福建醫藥雜志, 2014, 36(1):172-173.
6.	頡寶平, 李征, 姚南, 等. 化療聯合熱療治療晚期大腸癌療效及安全性的Meta分析[J]. 中國循證醫學雜志, 2013, 13(3):352-357.
7.	Willcox CR, Pitard V, Netzer S, et al. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor[J]. Nat Immunol, 2012, 13(9):872-879.
8.	Haber JS, Banu MA, Ray A, et al. Industry progress report on neuro-oncology:a biotech update[J]. J Neurooncol, 2013, 112(2):315-321.
9.	Saito M, Yano K, Kamigaki T, et al. A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA)[J]. Anticancer Res, 2013, 33(7):2957-2963.
10.	閆向勇, 劉文超. 熱療在腫瘤治療中的研究進展[J]. 世界中西醫結合雜志, 2014, 9(2):213-216.
11.	張佳慧, 秦麗娟. 腫瘤熱療的研究進展[J]. 實用心腦肺血管病雜志, 2012, 20(9):1424-1426.
12.	許士珍, 宋春燕, 王翠英. 康艾注射液聯合熱化療治療惡性胸腔積液80例[J]. 臨床薈萃, 2013, 28(11):1278-1279.
13.	黎玉梅, 彭美芳, 黃穎華, 等. ET-SPACE-Ⅰ型全身熱療系統治療惡性腫瘤護理體會[J]. 護士進修雜志, 2003, 18(11):988-990.
14.	陳艷芳. 惡性腫瘤患者行全身熱療聯合化療預防燙傷的護理[J]. 南方護理學報, 2005, 12(7):46-47.
15.	唐雯. 淺析全身熱療聯合化療治療晚期腫瘤110例[J]. 中國醫藥指南, 2013, 11(30):103-104.

1. 龔海云. 70例中晚期惡性腫瘤患者全身熱療的觀察與護理[J]. 當代護士:學術版, 2008(3):49-51.
2. 馬蕊. 惡性腫瘤患者全身熱療護理體會[J]. 中國現代藥物應用, 2010, 4(11):180-181.
3. 趙改梅, 方慧. 惡性腫瘤患者全身熱療的護理體會[J]. 實用醫藥雜志, 2008, 25(8):962-963.
4. 黃麗君, 徐惠芳, 宋俊瑩, 等. 腹部中晚期惡性腫瘤熱療的護理探討[J]. 中國臨床保健雜志, 2015, 5(2):214-215.
5. 鄭劍菁. 晚期腫瘤患者深部熱療護理體會[J]. 福建醫藥雜志, 2014, 36(1):172-173.
6. 頡寶平, 李征, 姚南, 等. 化療聯合熱療治療晚期大腸癌療效及安全性的Meta分析[J]. 中國循證醫學雜志, 2013, 13(3):352-357.
7. Willcox CR, Pitard V, Netzer S, et al. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor[J]. Nat Immunol, 2012, 13(9):872-879.
8. Haber JS, Banu MA, Ray A, et al. Industry progress report on neuro-oncology:a biotech update[J]. J Neurooncol, 2013, 112(2):315-321.
9. Saito M, Yano K, Kamigaki T, et al. A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA)[J]. Anticancer Res, 2013, 33(7):2957-2963.
10. 閆向勇, 劉文超. 熱療在腫瘤治療中的研究進展[J]. 世界中西醫結合雜志, 2014, 9(2):213-216.
11. 張佳慧, 秦麗娟. 腫瘤熱療的研究進展[J]. 實用心腦肺血管病雜志, 2012, 20(9):1424-1426.
12. 許士珍, 宋春燕, 王翠英. 康艾注射液聯合熱化療治療惡性胸腔積液80例[J]. 臨床薈萃, 2013, 28(11):1278-1279.
13. 黎玉梅, 彭美芳, 黃穎華, 等. ET-SPACE-Ⅰ型全身熱療系統治療惡性腫瘤護理體會[J]. 護士進修雜志, 2003, 18(11):988-990.
14. 陳艷芳. 惡性腫瘤患者行全身熱療聯合化療預防燙傷的護理[J]. 南方護理學報, 2005, 12(7):46-47.
15. 唐雯. 淺析全身熱療聯合化療治療晚期腫瘤110例[J]. 中國醫藥指南, 2013, 11(30):103-104.

Previous Article
Study on the Effect of Orem's Self-care Model in School-age Children with Asthma
Next Article
臨床護理路徑流程在食管癌圍手術期的應用及效果觀察

West China Medical Journal

Comparison of Application and Nursing between Continuous Hyperthermic Peritoneal Perfusion Chemotherapy and Intravenous Chemotherapy for Advanced Gastric Cancer Patients

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content